<?xml version="1.0" encoding="UTF-8"?>
<ref id="pntd.0007860.ref021">
 <label>21</label>
 <mixed-citation publication-type="journal">
  <name>
   <surname>Glassman</surname>
   <given-names>PM</given-names>
  </name>, 
  <name>
   <surname>Balthasar</surname>
   <given-names>JP</given-names>
  </name>. 
  <article-title>Mechanistic considerations for the use of monoclonal antibodies for cancer therapy</article-title>. 
  <source>Cancer biology &amp; medicine</source>. 
  <year>2014</year>;
  <volume>11</volume>(
  <issue>1</issue>):
  <fpage>20</fpage>â€“
  <lpage>33</lpage>. 
  <pub-id pub-id-type="doi">10.7497/j.issn.2095-3941.2014.01.002</pub-id>
  <?supplied-pmid 24738036?>
  <pub-id pub-id-type="pmid">24738036</pub-id>
 </mixed-citation>
</ref>
